Sichuan Dikang Sci & Tech Pharma.Ind., Ltd. (600466) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Sichuan Dikang Sci & Tech Pharma.Ind., Ltd. Company Snapshot

Business Description:

Sichuan Dikang Sci & Tech Pharma.Ind., Ltd. operates in the Pharmaceutical preparations sector. Sichuan Dikang Sci&Tech Pharmaceutical Industry Co., Ltd. is principally engaged in pharmaceutical production and distribution. The Company provides large transfusions, tablets, granules, capsules and other products, including amoxicillin capsules, ampicillin capsules, pieglitazone hydrochloride tablets and rabeprazole sodium enteric-coated tablets, among others. The Company also involves in manufacture and distribution of medical equipment. It distributes its products primarily in Chengdu, Sichuan province and Chongqing, China. As of December 31, 2010, the Company had four subsidiaries, which involved in the manufacture and distribution of pharmaceuticals and biological materials. In our complete report available for purchase the company is compared to: Skystar Bio-Pharmaceutical Company, Unisplendour Guhan Group Corporation Ltd and Jiangsu Liahuan Pharmaceutical Co., Ltd..

Sichuan Dikang Sci & Tech Pharma.Ind., Ltd.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 7.77
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	40.0%

4 Weeks	-8.7%	52 Weeks	81.5%

Sichuan Dikang Sci & Tech Pharma.Ind., Ltd. Key Data:

Ticker:	600466	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	322,154,000 (Year Ending Jan 2011).	Employees:	1,005

Currency:	Chinese Renmimbi	Market Cap:	3,411,075,493

Fiscal Yr Ends:	December	Shares Outstanding:	439,005,855

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.